Novel treatment avenues for peripheral T-cell lymphomas.
Hopfinger G, Griessl R, Sifft E, Taylor N, Kenner L, Greil R, Merkel O. Expert Opin Drug Discov. 2012 Dec,7(12):1149-63. doi: 10.1517/17460441.2012.727392. Epub 2012 Sep 24.
View this publication in the PUBMED databaseSkin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.
Thaler J, Karthaus M, Mineur L, Greil R, Letocha H, Hofheinz R, Fernebro E, Gamelin E, BaГѓВ±os A, KГ¶hne CH. BMC Cancer. 2012 Sep 29,12:438. doi: 10.1186/1471-2407-12-438.
View this publication in the PUBMED databaseWhat paths are open for tackling increasing azole resistance in Aspergillus in the clinic?
Auberger J, Greil R, Lass-FlГ¶rl C. Expert Rev Anti Infect Ther. 2012 Nov,10(11):1229-31. doi: 10.1586/eri.12.126.
View this publication in the PUBMED databaseAOP2014, a Novel Peg-Proline-Interferon Alpha-2b with Improved Pharmacokinetic Properties, Is Safe and Well Tolerated and Shows Promising Efficacy in Patients with Polycythemia Vera (PV)
Gisslinger, H, Kralovics, R, Gisslinger, B, Lechner, D, Buxhofer-Ausch, V, Strecker, K, Gastl, G, Willenbacher, E, Greil, R, Egle, A, Melchardt, T, Burgstaller, S, Schloegl, E, Tarmann, FJ, Zoerer, M, Klade, C, Zahriychuk, O, Thaler, J BLOOD. 2012, 120(21):
Complications of 5-azacytidine: Three cases of severe colitis in a single center cohort
Melchardt, T, Weiss, L, Pleyer, L, Steinkirchner, S, Greil, R, Egle, A ONKOLOGIE. 2012, 35: 149-149.
Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient
Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Morre, P, Boekstegers, A, Hopfinger, G, Greil, R, Egle, A BLOOD. 2012, 120(21):
Feasibility of anthracycline based treatment in unselected elderly DLBCL patients
Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Hopfinger, G, Greil, R, Egle, A ONKOLOGIE. 2012, 35: 86-87.
Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
Merkel O, Wacht N, Sifft E, Melchardt T, Hamacher F, Kocher T, Denk U, Hofbauer JP, Egle A, Scheideler M, Schlederer M, Steurer M, Kenner L, Greil R. Leukemia. 2012 Dec,26(12):2508-16. doi: 10.1038/leu.2012.147. Epub 2012 Jun 1.
View this publication in the PUBMED databaseChemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma – targets for therapeutic intervention?
JГ¶hrer K, Hofbauer SW, Zelle-Rieser C, Greil R, Hartmann TN. Expert Opin Biol Ther. 2012 Apr,12(4):425-41. doi: 10.1517/14712598.2012.664128. Epub 2012 Feb 15.
View this publication in the PUBMED databaseCanonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.
Aberger F, Kern D, Greil R, Hartmann TN. Vitam Horm. 2012,88:25-54. doi: 10.1016/B978-0-12-394622-5.00002-X.
View this publication in the PUBMED database